ARTICLE | Strategy
MedImmune's pipeline
April 30, 2007 7:00 AM UTC
MedImmune's 45 development projects, including 12 in the clinic for 14 indications, will increase the proportion of biologics in AstraZeneca's pipeline to 27% from 7%. MEDI also markets Synagis palivi...